SLDB · Solid Biosciences Inc. · Debt
$6.25
-0.19 (-2.95%)
At close · Nov 20
Return incl. dividend (before tax)
Q1 2022 earnings call transcript
Market Cap
$697.57M
Shares
111.61M
Volume · Nov 20
1.56M
Avg daily vol (3M)
1.29M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Debt Profile
Completed filing coverage through Jun 16, 2021Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Read debt and covenant terms in your AI or your code through MCP and the API →Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-09-30 | USD 2,284,000 | 10-Q filed 2026-11-04 |
| Noncurrent operating lease liabilities | 2026-09-30 | USD 17,340,000 | 10-Q filed 2026-11-04 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1707502
CUSIP
83422E204
13F (30d)
160 filings
144 filers
Visit website
Investor relations